New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 5, 2013
06:36 EDTNBIXNeurocrine Biosciences initiated with a Buy at Lazard Capital
Target $13.
News For NBIX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
May 22, 2015
07:14 EDTNBIXNeurocrine price target raised to $64 from $56 at Piper Jaffray
Subscribe for More Information
May 13, 2015
11:10 EDTNBIXNeurocrine holds analyst and investor day
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use